A stepwise HIV vaccine strategy has induced broadly neutralizing antibodies in primates, hinting that a truly protective HIV ...
July 21 (Reuters) - Gilead Sciences and Merck said on Tuesday their experimental once-weekly HIV pill kept the virus ...
Around one million individuals worldwide become infected with HIV, the virus that causes AIDS, each year. To replicate and spread the infection, the virus must smuggle its genetic material into the ...
HIV virus is one of the most pressing health concerns facing the modern world. Since the first reported case of HIV/AIDS in 1981, over 25 million people have died. Out of the millions of people ...
Scientists have taken a major step toward developing an effective HIV vaccine after a new experimental vaccine successfully generated high levels of broadly ne ...
Researchers at the Department of Medicine, Huddinge, have presented new research on how some people with HIV can control the virus without treatment. The results show that gut bacteria and a specific ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. We might be a step closer to curing HIV, as researchers have developed ...
At the cellular level, HIV-1 transmission involves a highly coordinated process whereby the virus binds to CD4 receptors and one of two coreceptors—CCR5 (R5) or CXCR4 (X4)—on host immune cells, ...
A UCSF study finds controlling HIV is not enough when trauma, addiction, mental illness and housing instability continue to ...
In the study published in the journal Emerging Microbes and Infections, the team demonstrated that the patented therapeutic candidate, an HIV-virus-like-particle (HLP), is 100 times more effective ...
People with HIV have a virus that spreads in their body and damages the immune system, making it easier for them to get very sick from other infections. The medicine contained in Sunlenca works ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results